GRI Bio, Inc. (GRI) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.37
Day's range
$2.51

GRI Bio Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HRT FINANCIAL LP 08/14/2026 28.78 K $50.00 K   100.00% 1.59%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 21.37 K $37.82 K   100.00% 1.18%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 13.87 K $24.55 K   -24.78% 0.77%
CITADEL ADVISORS LLC 09/02/2026 13.38 K $23.68 K   100.00% 0.74%
MORGAN STANLEY 08/13/2026 8.74 K $15.46 K   100.00% 0.48%
UBS GROUP AG 08/13/2026 4.92 K $8.71 K   -43.59% 0.27%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 2.43 K $4.31 K   129.62% 0.13%
BARCLAYS PLC 08/14/2026 83 $147   100.00% 0.00%
BLACKROCK, INC. 08/07/2026 7 $12   0.00% 0.00%
DANSKE BANK A/S 08/10/2026 2 $4   0.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 08/05/2026 2 $4   100.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 0 $0   -100.00% 0.00%

GRI Bio Inc institutional Ownership - FAQ's

During the previous two years, 12 institutional investors and hedge funds held shares of GRI Bio Inc. The most heavily invested institutionals were:

HRT FINANCIAL LP: 28,784

VANGUARD CAPITAL MANAGEMENT LLC: 21,368

GEODE CAPITAL MANAGEMENT, LLC: 13,869

CITADEL ADVISORS LLC: 13,376

MORGAN STANLEY: 8,737

UBS Group AG: 4,920

5.18% of GRI Bio Inc stock is owned by institutional investors.

Institutional investors have bought a total of 93.58 K shares in the last 24 months. This purchase volume represents approximately $234.89 K in transactions.